Log in to save to my catalogue

Psychotomimetic compensation versus sensitization

Psychotomimetic compensation versus sensitization

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fb507da3d274287b0fb7a9fabec4b95

Psychotomimetic compensation versus sensitization

About this item

Full title

Psychotomimetic compensation versus sensitization

Publisher

United States: John Wiley & Sons, Inc

Journal title

Pharmacology research & perspectives, 2024-08, Vol.12 (4), p.e1217-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

It is a paradox that psychotomimetic drugs can relieve symptoms that increase risk of and cooccur with psychosis, such as attention and motivational deficits (e.g., amphetamines), pain (e.g., cannabis) and symptoms of depression (e.g., psychedelics, dissociatives). We introduce the ideas of psychotomimetic compensation and psychotomimetic sensitiza...

Alternative Titles

Full title

Psychotomimetic compensation versus sensitization

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9fb507da3d274287b0fb7a9fabec4b95

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fb507da3d274287b0fb7a9fabec4b95

Other Identifiers

ISSN

2052-1707

E-ISSN

2052-1707

DOI

10.1002/prp2.1217

How to access this item